04/11/2024
3:05 PM | Merck & Co., Inc. (Filer)
| Form 10-K/A | |
04/11/2024
3:08 PM | Merck & Co., Inc. (Filer)
| Form DEF 14A | |
04/11/2024
3:10 PM | Merck & Co., Inc. (Filer)
| Form DEFA14A | |
04/11/2024
3:12 PM | Merck & Co., Inc. (Filer)
| Form ARS | |
04/08/2024
12:56 PM | Larson Betty D (Reporting)
Merck & Co., Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2024
4:16 PM | Inspire Investing, LLC (Filed by)
Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/29/2024
3:12 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/29/2024
3:14 PM | GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:16 PM | Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:18 PM | Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:57 PM | Bowyer Research, Inc. (Filed by)
Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/11/2024
2:27 PM | Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:24 PM | Davis Robert M (Reporting)
Merck & Co., Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
3:01 PM | Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:35 PM | Merck & Co., Inc. (Subject)
Oosthuizen Johannes Jacobus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
5:39 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
2:29 PM | Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
| Form SC 13G | |
01/17/2024
4:52 PM | Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:27 PM | Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:18 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
4:27 PM | Merck & Co., Inc. (Issuer)
Smart Dalton (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2023
6:36 AM | Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
8:04 AM | DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
2:49 PM | Downing Cristal N (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
10:08 AM | Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
5:38 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
2:45 PM | Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
2:20 PM | GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
2:33 PM | Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
2:04 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
3:12 PM | Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023
5:46 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
3:53 PM | Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
3:36 PM | GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
3:21 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
1:09 PM | Merck & Co., Inc. (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/27/2023
1:10 PM | Merck & Co., Inc. (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/27/2023
1:11 PM | Merck & Co., Inc. (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
05/31/2023
3:20 PM | LAVIZZO-MOUREY RISA J (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
1:55 PM | Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
2:08 PM | Merck & Co., Inc. (Issuer)
Warden Kathy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
“The Biggest Bubble of All Time” – Here’s What to Do. (Ad) Despite AI's incredible run-up in 2023, we're getting some conflicting messages.
Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down.
Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse.
Even AI leaders (the people who benefit the most!) are getting worried. Just click here. |
05/31/2023
2:11 PM | Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
1:07 PM | BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
8:00 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
7:58 PM | Merck & Co., Inc. (Subject)
| Form FWP | |
05/08/2023
7:17 AM | Merck & Co., Inc. (Filer)
| Form 424B5 | |
05/05/2023
4:13 PM | Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:19 PM | Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
6:39 AM | Merck & Co., Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
5:11 PM | Davis Robert M (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:14 PM | DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:18 PM | Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:22 PM | Merck & Co., Inc. (Issuer)
Williams David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:26 PM | Klobuchar Michael A (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:29 PM | Litchfield Caroline (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:33 PM | Karachun Rita A (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:37 PM | LeCointe-Cephas Lisa (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:47 PM | Downing Cristal N (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:50 PM | Merck & Co., Inc. (Issuer)
Romanelli Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:56 PM | Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:01 PM | Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:34 PM | Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:40 PM | Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:43 PM | Guindo Chirfi (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
3:30 PM | Merck & Co., Inc. (Subject)
Zachary Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023
3:08 PM | Karachun Rita A (Reporting)
Merck & Co., Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2023
3:24 PM | Karachun Rita A (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
3:28 PM | Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2023
3:10 PM | Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
2:00 PM | Klobuchar Michael A (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
2:11 PM | LeCointe-Cephas Lisa (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
10:37 AM | DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2023
3:30 PM | DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2023
4:15 PM | Davis Robert M (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
3:28 PM | Davis Robert M (Reporting)
Merck & Co., Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/27/2023
5:43 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
